# Post-Morning Agentic Market Scan — 2026-07-07

Timestamp: 2026-07-07 13:50 UTC
Account: Robinhood Agentic ending 1041 / 433711041
Mode: Research/reporting. Autonomous policy file is ACTIVE, but no trade placed because best candidates were extended/event-driven or market/account risk did not justify adding exposure.

## Account state

- Portfolio value: $195.1556
- Equity value: $141.4156
- Cash / buying power: $53.74
- Deployment: ~72.46% in equities, ~27.54% cash
- Open equity positions:
  - SOFI: 4.47758 sh, avg $17.87, quote $18.34, market value ~$82.12, unrealized P/L ~$2.10 / +2.63%
  - AMD: 0.115059 sh, avg $521.47, quote $514.075, market value ~$59.15, unrealized P/L ~-$0.85 / -1.42%
- Option positions: none
- Open equity orders checked in states new, queued, confirmed, unconfirmed, partially_filled: none found
- Recent equity orders since 2026-07-01: none returned

## Broad market

- SPY: $749.715, -0.21% vs prior close
- QQQ: $712.22, -1.47% vs prior close
- IWM: $297.44, -0.49% vs prior close
- VIXY: $20.75, +0.48%
- Read: cautious/neutral-to-bearish at the open; tech/QQQ is the weak link, small caps slightly better but still red.

## Sources checked

- Robinhood MCP: accounts, portfolio, equity/option positions, open-order states, recent orders, popular lists, Daily Movers, quotes, tradability, fundamentals, historicals.
- Gmail personal-main: auth valid for Gmail; routed TLDR/Robinhood Snacks query for the last 3 days returned no messages. Calendar/Drive scopes are still insufficient on this token but not needed for this scan.
- Web/news: searched current movers and specific context for AMD, SOFI, RIVN, CRNX, DOCN, AGIO.

## Candidate scan

Daily Movers / broad scan highlights:

- CRNX: $83.505, +98.68% vs prior close. 52-week high today, massive volume ~41.8M vs ~2.1M avg. Catalyst context: endocrine/rare-disease drug data/news flow; recent Phase 2 atumelnant and paltusotine/rare endocrine pipeline coverage. Setup quality: high liquidity today but gap is extreme and price is pinned near opening range; no safe stop from current price for the sandbox without waiting for a retest/base. No trade.
- AGIO: $42.29, +13.11%. Rare-disease hematology catalyst; FDA priority review / sNDA context for mitapivat in sickle-cell disease with PDUFA Nov. 1. Technicals: gap above recent $37-$38 range toward $42, below 52-week high $46. Support/invalidation: $39.40 intraday low / gap zone. Setup quality: better than CRNX for contained biotech momentum, but current volume at scan time was below avg and biotech headline risk is high. Watch only.
- DOCN: $140.53, +6.97%. AI-native cloud narrative, Q1 beat, AI ARR growth, prior index/upgrade catalysts; today is a bounce from a sharp multi-week drawdown. Technicals: still below recent June highs and below the early-June range; resistance $146-$150 then $157. Support/invalidation: $139.50 intraday low / $130 prior close zone. Setup quality: possible bounce but still a broken short-term trend; wait for reclaim of $146-$150 or a controlled pullback.
- RIVN: $17.63, -12.46%. Catalyst is negative despite earlier delivery strength: 75M-share offering / $1.5B raise overshadowed Q2 revenue/delivery positives. Technicals: failed after two-day breakout to $20.14, now back near prior breakout area. Invalidation for longs would be under $17.20-$17.00; catalyst disconfirms momentum, so no add.
- AMD: $514.075, -6.88%. Existing small position. AI-chip narrative still intact longer term, but market is punishing high-expectation semis today; QQQ also weak. Technicals: below prior close $552 and below recent high $584.73; support zone $506-$510 from recent lows. Management: hold only while above ~$506-$509; review exit if it loses that zone with QQQ still weak.
- SOFI: $18.34, -1.45%. Existing largest position; strong Q1 growth/EBITDA narrative from sources, but stock is consolidating below $19.10-$19.20 recent resistance. Support/invalidation: $17.75-$18.00 near recent lows; thesis weakens below $17.75. Management: hold; no add until reclaim/hold over ~$18.75-$19.20.

## Best setup / decision

- Best actionable idea: no new trade right now.
- Reason: account is already inside target deployment at ~72%, broad market is soft, AMD is under pressure, and the strongest fresh movers are event-driven gaps with poor entry quality for a $195 account.
- Watchlist trigger if later scan sees improvement:
  - AGIO over $42.60 with volume expansion and a stop under $39.40 could be considered as a small starter, but only if the spread remains tight and risk math is acceptable.
  - DOCN over $146.50-$150 with market confirmation could become a bounce/reclaim setup.
  - SOFI add only on reclaim/hold above $18.75-$19.20 or pullback holding $17.75-$18.00.

## Risk / invalidation

- Portfolio kill switch not triggered: account value is above $10 and broker state is clear.
- No forced deployment: current equity deployment already ~72.46%, within the 70%-90% target range.
- Existing position risk:
  - AMD: review/possible exit if price loses ~$506-$509 support with QQQ weak.
  - SOFI: review/possible trim/exit if it loses ~$17.75-$18.00.
- No options, no shorts, no non-Agentic accounts touched.

## Tool / system upgrades

- Add a compact scanner script that takes Robinhood Daily Movers symbols, filters OTC/wide spreads, computes SMA10/SMA20/ATR14/relative volume, and emits only a small ranked JSON summary.
- Add a Gmail-label probe that searches exact routed labels such as Hermes/Finance/Robinhood plus TLDR aliases instead of broad from:/keyword searches.
- Add an MCP/screener preset for: price > $5, avg volume > 500k, today move 3%-15%, relative volume > 1.5x, fractional tradable, spread < 0.25%.
- Add position-management guardrails that convert planned invalidation levels into explicit scan alerts for SOFI and AMD.

## Trade action

- No order preview or placement performed.
- Journal updated by scheduled scan.
